Evidence-Based Medicine Guidelines
Golimumab for rheumatoid arthritis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Golimumab for Rheumatoid Arthritis." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457010/all/_________Golimumab_for_rheumatoid_arthritis______.
Golimumab for rheumatoid arthritis. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/457010/all/_________Golimumab_for_rheumatoid_arthritis______. Accessed April 9, 2025.
Golimumab for rheumatoid arthritis. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/457010/all/_________Golimumab_for_rheumatoid_arthritis______
Golimumab for Rheumatoid Arthritis [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457010/all/_________Golimumab_for_rheumatoid_arthritis______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Golimumab for rheumatoid arthritis
ID - 457010
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457010/all/_________Golimumab_for_rheumatoid_arthritis______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
